San Francisco Biotech →
June 21st, 2015
Bluebird Bio (NASDAQ: BLUE) hired former Sangamo Biosciences (NASDAQ: SGMO) chief scientific officer and research chief Phillip Gregory as its new CSO.
Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at firstname.lastname@example.org Follow @benthefidler
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.